Physician profile
Pagiel Shechter
NPI 1093767337
$1,052.03
in general payments reported to CMS, 2019-2025
17 companies · $453 in 2025
The $453 reported for 2025 was more than what a typical Nephrology (Internal Medicine) provider received nationally (typical 2025 total: $311).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $32.86 · 2020: $85.37 · 2021: $78.52 · 2022: $123 · 2023: $52.05 · 2024: $227 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $732.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $732.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ardelyx, INC. | $269.88 | 2024-2025 | Ibsrela |
| Novartis Pharmaceuticals Corporation | $141.09 | 2021-2025 | |
| Calliditas Therapeutics US INC. | $85.18 | 2024-2025 | Tarpeyo |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $75.87 | 2025 | Caplyta |
| Bayer Healthcare Pharmaceuticals INC. | $60.29 | 2022-2025 | |
| Novo Nordisk INC | $53.56 | 2021-2025 | Rivfloza |
| Astrazeneca Pharmaceuticals LP | $52.58 | 2023-2024 | Farxiga, Fasenra |
| Opko Pharmaceuticals, LLC | $46.78 | 2025 | Rayaldee |
| Medtronic Minimed, INC. | $44.59 | 2020 | |
| Mannkind Corporation | $40.78 | 2020 | |
| Alnylam Pharmaceuticals INC. | $39.86 | 2025 | Oxlumo |
| Akebia Therapeutics INC | $36.70 | 2019-2021 | |
| Abbott Laboratories | $27.90 | 2024 | Freestyle Libre 3 |
| Cmp Pharma, INC. | $25.21 | 2022 | |
| Sunovion Pharmaceuticals INC. | $21.16 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $18.47 | 2022 | |
| Eisai INC. | $12.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pagiel Shechter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.